{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:14:44Z","timestamp":1794964484343,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009782","name":"Ruth och Richard Julins Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005754","name":"Sahlgrenska Universitetssjukhuset","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003745","name":"Stiftelserna Wilhelm och Martina Lundgrens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002706","name":"AFA F\u00f6rs\u00e4kring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007308","name":"Sveriges L\u00e4karf\u00f6rbund","doi-asserted-by":"publisher","award":["13409, 21691 and 21692"],"award-info":[{"award-number":["13409, 21691 and 21692"]}],"id":[{"id":"10.13039\/501100007308","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Faculty of Medicine, University of Gothenburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Altered bacterial composition and small intestinal bacterial overgrowth (SIBO) may be associated with irritable bowel syndrome (IBS). This study aimed to determine the fecal and mucosa-associated bacterial composition along the gastrointestinal (GI) tract and to assess SIBO in IBS. Bacterial composition of feces, and mucosa of the duodenum and sigmoid colon was determined by 16S rRNA-amplicon-sequencing. SIBO was evaluated by bacterial culture of duodenal aspirate, glucose and lactulose breath tests. Mucosal antibacterial gene expression was assessed by PCR Array. The bacterial profiles of feces and the mucosa of sigmoid colon, but not duodenum, differed between IBS patients (n\u2009=\u200917) and HS (n\u2009=\u200920). The IBS specific bacterial profiles were linked to the colonic antibacterial gene expression. Fecal bacterial profile differed between IBS subtypes, while the mucosa-associated bacterial profile was associated with IBS symptom severity and breath tests results at baseline (H<jats:sub>2<\/jats:sub> and\/or CH<jats:sub>4<\/jats:sub>\u2009\u2265\u200915 ppm). The prevalence of SIBO was similar between IBS patients and HS. This study demonstrates that alterations in the bacterial composition of the sigmoid colon of IBS patients were linked to symptoms and immune activation. While breath tests reflected the mucosa-associated bacterial composition, there was no evidence for high prevalence of SIBO or small intestinal bacterial alterations in IBS.<\/jats:p>","DOI":"10.1038\/s41598-020-57468-y","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T11:03:13Z","timestamp":1579258993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome"],"prefix":"10.1038","volume":"10","author":[{"given":"Johanna","family":"Sundin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Nordlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annikka","family":"Polster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2025-2198","authenticated-orcid":false,"given":"Yue O. O.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5432-1764","authenticated-orcid":false,"given":"Luisa W.","family":"Hugerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra A. L.","family":"Pennhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Engstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"T\u00f6rnblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Simr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"\u00d6hman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"57468_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/17474124.2017.1292130","volume":"11","author":"WE Whitehead","year":"2017","unstructured":"Whitehead, W. E., Palsson, O. S. & Simren, M. Irritable bowel syndrome: what do the new Rome IV diagnostic guidelines mean for patient management? Expert Rev Gastroenterol Hepatol 11, 281\u2013283, https:\/\/doi.org\/10.1080\/17474124.2017.1292130 (2017).","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"57468_CR2","doi-asserted-by":"publisher","unstructured":"Chen, B., Kim, J. J., Zhang, Y., Du, L. & Dai, N. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis. J Gastroenterol, https:\/\/doi.org\/10.1007\/s00535-018-1476-9 (2018).","DOI":"10.1007\/s00535-018-1476-9"},{"key":"57468_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/ard.2003.011502","volume":"63","author":"M Pimentel","year":"2004","unstructured":"Pimentel, M. et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis 63, 450\u2013452 (2004).","journal-title":"Ann Rheum Dis"},{"key":"57468_CR4","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jpeds.2009.03.033","volume":"155","author":"E Scarpellini","year":"2009","unstructured":"Scarpellini, E. et al. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr 155, 416\u2013420, https:\/\/doi.org\/10.1016\/j.jpeds.2009.03.033 (2009).","journal-title":"J Pediatr"},{"key":"57468_CR5","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.26355\/eurrev_201711_13839","volume":"21","author":"XW Ding","year":"2017","unstructured":"Ding, X. W. et al. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome. Eur Rev Med Pharmacol Sci 21, 5191\u20135196, https:\/\/doi.org\/10.26355\/eurrev_201711_13839 (2017).","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"57468_CR6","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","volume":"16","author":"J Bures","year":"2010","unstructured":"Bures, J. et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 16, 2978\u20132990 (2010).","journal-title":"World J Gastroenterol"},{"key":"57468_CR7","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1128\/JB.00345-12","volume":"194","author":"EJ Stewart","year":"2012","unstructured":"Stewart, E. J. Growing unculturable bacteria. J Bacteriol 194, 4151\u20134160, https:\/\/doi.org\/10.1128\/JB.00345-12 (2012).","journal-title":"J Bacteriol"},{"key":"57468_CR8","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.cgh.2009.06.031","volume":"7","author":"AC Ford","year":"2009","unstructured":"Ford, A. C., Spiegel, B. M., Talley, N. J. & Moayyedi, P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 7, 1279\u20131286, https:\/\/doi.org\/10.1016\/j.cgh.2009.06.031 (2009).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"57468_CR9","doi-asserted-by":"crossref","unstructured":"Jeffery, I. B. et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61 (2012).","DOI":"10.1136\/gutjnl-2011-301501"},{"key":"57468_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","volume":"152","author":"J Tap","year":"2017","unstructured":"Tap, J. et al. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. Gastroenterology 152, 111\u2013123 e118, https:\/\/doi.org\/10.1053\/j.gastro.2016.09.049 (2017).","journal-title":"Gastroenterology"},{"key":"57468_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/apt.13055","volume":"41","author":"J Sundin","year":"2015","unstructured":"Sundin, J. et al. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. Aliment Pharmacol Ther. 41, 342\u2013351 (2015).","journal-title":"Aliment Pharmacol Ther."},{"key":"57468_CR12","doi-asserted-by":"publisher","unstructured":"Bennet, S. M. P. et al. Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation. Neurogastroenterol Motil, e13468, https:\/\/doi.org\/10.1111\/nmo.13468 (2018).","DOI":"10.1111\/nmo.13468"},{"key":"57468_CR13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3109\/00365521.2015.1027261","volume":"50","author":"E Giamarellos-Bourboulis","year":"2015","unstructured":"Giamarellos-Bourboulis, E. et al. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scand J Gastroenterol 50, 1076\u20131087, https:\/\/doi.org\/10.3109\/00365521.2015.1027261 (2015).","journal-title":"Scand J Gastroenterol"},{"key":"57468_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep08508","volume":"5","author":"A Dlugosz","year":"2015","unstructured":"Dlugosz, A. et al. No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Sci Rep 5, 8508, https:\/\/doi.org\/10.1038\/srep08508 (2015).","journal-title":"Sci Rep"},{"key":"57468_CR15","doi-asserted-by":"publisher","first-page":"3230859","DOI":"10.1155\/2016\/3230859","volume":"2016","author":"H Chu","year":"2016","unstructured":"Chu, H. et al. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterol Res Pract 2016, 3230859, https:\/\/doi.org\/10.1155\/2016\/3230859 (2016).","journal-title":"Gastroenterol Res Pract"},{"key":"57468_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1264\/jsme2.ME17017","volume":"32","author":"ET Hillman","year":"2017","unstructured":"Hillman, E. T., Lu, H., Yao, T. & Nakatsu, C. H. Microbial Ecology along the Gastrointestinal Tract. Microbes Environ 32, 300\u2013313, https:\/\/doi.org\/10.1264\/jsme2.ME17017 (2017).","journal-title":"Microbes Environ"},{"key":"57468_CR17","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"BE Lacy","year":"2016","unstructured":"Lacy, B. E. et al. Bowel Disorders. Gastroenterology 150, 1393\u20131407 (2016).","journal-title":"Gastroenterology"},{"key":"57468_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","volume":"65","author":"D Vandeputte","year":"2016","unstructured":"Vandeputte, D. et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 57\u201362, https:\/\/doi.org\/10.1136\/gutjnl-2015-309618 (2016).","journal-title":"Gut"},{"key":"57468_CR19","doi-asserted-by":"publisher","unstructured":"Diether, N. E. & Willing, B. P. Microbial Fermentation of Dietary Protein: An Important Factor in Diet(-)Microbe(-)Host Interaction. Microorganisms 7, https:\/\/doi.org\/10.3390\/microorganisms7010019 (2019).","DOI":"10.3390\/microorganisms7010019"},{"key":"57468_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrgastro.2014.200","volume":"12","author":"L Ohman","year":"2015","unstructured":"Ohman, L., Tornblom, H. & Simren, M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 12, 36\u201349, https:\/\/doi.org\/10.1038\/nrgastro.2014.200 (2015).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"57468_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.07.026","author":"R Guo","year":"2019","unstructured":"Guo, R., Chen, L. H., Xing, C. & Liu, T. Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential. Br J Anaesth. https:\/\/doi.org\/10.1016\/j.bja.2019.07.026 (2019).","journal-title":"Br J Anaesth"},{"key":"57468_CR22","doi-asserted-by":"publisher","unstructured":"Mancabelli, L. et al. Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis. FEMS Microbiol Ecol 93, https:\/\/doi.org\/10.1093\/femsec\/fix153 (2017).","DOI":"10.1093\/femsec\/fix153"},{"key":"57468_CR23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/cea.12566","volume":"45","author":"CE West","year":"2015","unstructured":"West, C. E. et al. Gut microbiome and innate immune response patterns in IgE-associated eczema. Clin Exp Allergy 45, 1419\u20131429, https:\/\/doi.org\/10.1111\/cea.12566 (2015).","journal-title":"Clin Exp Allergy"},{"key":"57468_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrmicro1817","volume":"6","author":"HJ Flint","year":"2008","unstructured":"Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R. & White, B. A. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 6, 121\u2013131, https:\/\/doi.org\/10.1038\/nrmicro1817 (2008).","journal-title":"Nat Rev Microbiol"},{"key":"57468_CR25","doi-asserted-by":"crossref","unstructured":"Sundin, J., Rangel, I., Kumawat, A. K., Hultgren-H\u00f6rnquist, E. & Brummer, R. J. Aberrant mucosal lymphocyte number and subsets in the colon of post-infectious irritable bowel syndrome patients. Scand J Gastroenterol. 49 (2014).","DOI":"10.3109\/00365521.2014.926982"},{"key":"57468_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/ajg.2016.223","volume":"111","author":"SMP Bennet","year":"2016","unstructured":"Bennet, S. M. P. et al. Global cytokine profiles and association with clinical characteristics in patients with irritable bowel syndrome. American Journal of Gastroenterology 111, 1165\u20131176 (2016).","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl 1","key":"57468_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2036.2009.03951.x","volume":"29","author":"A Gasbarrini","year":"2009","unstructured":"Gasbarrini, A. et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 29(Suppl 1), 1\u201349, https:\/\/doi.org\/10.1111\/j.1365-2036.2009.03951.x (2009).","journal-title":"Aliment Pharmacol Ther"},{"key":"57468_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ajg.2017.46","volume":"112","author":"A Rezaie","year":"2017","unstructured":"Rezaie, A. et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol 112, 775\u2013784, https:\/\/doi.org\/10.1038\/ajg.2017.46 (2017).","journal-title":"Am J Gastroenterol"},{"key":"57468_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/gut.2005.075127","volume":"55","author":"M Simr\u00e9n","year":"2006","unstructured":"Simr\u00e9n, M. & Stotzer, P. O. Use and abuse of hydrogen breath tests. Gut 55, 297\u2013303 (2006).","journal-title":"Gut"},{"key":"57468_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bpg.2013.03.001","volume":"27","author":"JP Ouwerkerk","year":"2013","unstructured":"Ouwerkerk, J. P., de Vos, W. M. & Belzer, C. Glycobiome: bacteria and mucus at the epithelial interface. Best Pract Res Clin Gastroenterol 27, 25\u201338, https:\/\/doi.org\/10.1016\/j.bpg.2013.03.001 (2013).","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"57468_CR31","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1111\/j.1462-2920.2010.02294.x","volume":"12","author":"CC Booijink","year":"2010","unstructured":"Booijink, C. C. et al. High temporal and inter-individual variation detected in the human ileal microbiota. Environ Microbiol 12, 3213\u20133227 (2010).","journal-title":"Environ Microbiol"},{"key":"57468_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.femsim.2004.08.009","volume":"43","author":"J Matto","year":"2005","unstructured":"Matto, J. et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome\u2013a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43, 213\u2013222 (2005).","journal-title":"FEMS Immunol Med Microbiol"},{"key":"57468_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1099\/jmm.0.46134-0","volume":"55","author":"J Maukonen","year":"2006","unstructured":"Maukonen, J. et al. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 55, 625\u2013633, https:\/\/doi.org\/10.1099\/jmm.0.46134-0 (2006).","journal-title":"J Med Microbiol"},{"key":"57468_CR34","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1136\/gutjnl-2013-305994","volume":"63","author":"J Jalanka-Tuovinen","year":"2014","unstructured":"Jalanka-Tuovinen, J. et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 63, 1737\u20131745 (2014).","journal-title":"Gut"},{"key":"57468_CR35","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41395-018-0074-z","volume":"113","author":"I Aziz","year":"2018","unstructured":"Aziz, I., Tornblom, H., Palsson, O. S., Whitehead, W. E. & Simren, M. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. Am J Gastroenterol 113, 1017\u20131025, https:\/\/doi.org\/10.1038\/s41395-018-0074-z (2018).","journal-title":"Am J Gastroenterol"},{"key":"57468_CR36","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth, G. F. et al. Functional bowel disorders. Gastroenterology 130, 1480\u20131491, https:\/\/doi.org\/10.1053\/j.gastro.2005.11.061 (2006).","journal-title":"Gastroenterology"},{"key":"57468_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00004836-200007000-00015","volume":"31","author":"F Castiglione","year":"2000","unstructured":"Castiglione, F. et al. Orocecal transit time and bacterial overgrowth in patients with Crohn\u2019s disease. J Clin Gastroenterol 31, 63\u201366 (2000).","journal-title":"J Clin Gastroenterol"},{"key":"57468_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5009\/gnl.2009.3.3.174","volume":"3","author":"JH Park","year":"2009","unstructured":"Park, J. H. et al. The Relationship between Small-Intestinal Bacterial Overgrowth and Intestinal Permeability in Patients with Irritable Bowel Syndrome. Gut Liver 3, 174\u2013179, https:\/\/doi.org\/10.5009\/gnl.2009.3.3.174 (2009).","journal-title":"Gut Liver"},{"key":"57468_CR39","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/MEG.0000000000000122","volume":"26","author":"UC Ghoshal","year":"2014","unstructured":"Ghoshal, U. C., Srivastava, D., Ghoshal, U. & Misra, A. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Eur J Gastroenterol Hepatol 26, 753\u2013760, https:\/\/doi.org\/10.1097\/MEG.0000000000000122 (2014).","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"57468_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/00365527909179892","volume":"14","author":"JM Rhodes","year":"1979","unstructured":"Rhodes, J. M., Middleton, P. & Jewell, D. P. The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol 14, 333\u2013336 (1979).","journal-title":"Scand J Gastroenterol"},{"key":"57468_CR41","doi-asserted-by":"crossref","unstructured":"Hugerth, L. W. et al. A comprehensive automated pipeline for human microbiome sampling, 16S rRNA gene sequencing and bioinformatics processing. bioRxiv Mars 21 (2018).","DOI":"10.1101\/286526"},{"key":"57468_CR42","unstructured":"Umetrics. SIMCA-P and Multivariate Analysis FAQ. Version 1.01. Accessed 26 September (2016)."},{"key":"57468_CR43","unstructured":"Eriksson, L., Kettaneh-Wold, N., Trygg, J., Wikstr\u00f6m, C. & Wold, S. (Umetrics Inc, 2006)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57468-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57468-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57468-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T05:57:30Z","timestamp":1670306250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57468-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["57468"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-57468-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,17]]},"assertion":[{"value":"5 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.S., I.A., S.N., A.P., Y.H., L.H., A.P. and L.E.: No competing interests\u2019 or non-financial competing interests. H.T: Has served as a Consultant\/ Advisory Board member for Almirall, Allergan and Shire, and as a speaker for Tillotts, Takeda, Shire, and Almirall. MS: Received unrestricted research grants from Danone, Glycom and Ferring Pharmaceuticals, and served as a Consultant\/Advisory Board member for AstraZeneca, Danone, Nestl\u00e9, Almirall, Allergan, Albireo, Glycom, Menarini and Shire, and as a speaker for Tillotts, Menarini, Biocodex, AlfaSigma, Alimentary Health, Takeda, Shire, Allergan, and Almirall. L.\u00d6.: Has received a financial support for research by Danone Research and AstraZeneca and served as an advisory board member for Genetic Analyses and as speaker for Abbvie, Takeda, Janssen and Tillots.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"593"}}